Literature DB >> 11930099

Listeria meningitis after treatment with infliximab.

Binita M Kamath1, Petar Mamula, Robert N Baldassano, Jonathan E Markowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11930099     DOI： 10.1097/00005176-200204000-00018

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  15 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 2.  Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?

Authors:  Theodoros Kelesidis; Amandeep Salhotra; Jorge Fleisher; Daniel Z Uslan
Journal:  J Infect       Date:  2010-02-20       Impact factor: 6.072

Review 3.  Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.

Authors:  Nirmal Kaur; Thomas C Mahl
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

4.  Septicemic listeriosis during adalimumab- and golimumab-based treatment for ulcerative colitis: case presentation and literature review.

Authors:  Ryoko Horigome; Hiroki Sato; Terasu Honma; Shuji Terai
Journal:  Clin J Gastroenterol       Date:  2019-06-20

Review 5.  Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.

Authors:  D C Sadowski; C N Bernstein; A Bitton; K Croitoru; R N Fedorak; A Griffiths
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

6.  Listeriosis in patients receiving biologic therapies.

Authors:  M Bodro; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-09       Impact factor: 3.267

Review 7.  New therapies for rheumatoid arthritis.

Authors:  F Goldblatt; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 8.  Biologic treatments for systemic rheumatic diseases.

Authors:  Y Shirota; G G Illei; N P Nikolov
Journal:  Oral Dis       Date:  2008-02-14       Impact factor: 3.511

9.  Listeria meningitis complicating infliximab treatment for Crohn's disease.

Authors:  Geoffrey Williams; Asad A Khan; Franzjosef Schweiger
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

Review 10.  Infliximab therapy in children and adolescents with inflammatory bowel disease.

Authors:  Gabor Veres; Robert N Baldassano; Petar Mamula
Journal:  Drugs       Date:  2007       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.